These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 26867018)

  • 1. Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial.
    Carlsson S; Jäderling F; Wallerstedt A; Nyberg T; Stranne J; Thorsteinsdottir T; Carlsson SV; Bjartell A; Hugosson J; Haglind E; Steineck G
    BJU Int; 2016 Aug; 118(2):205-12. PubMed ID: 26867018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing a new, simple scoring system to evaluate oncological and functional outcome after radical prostatectomy.
    Salomon L; Anastasiadis A; Saint F; De La Taille A; Chopin D; Abbou CC
    Scand J Urol Nephrol; 2003; 37(5):392-5. PubMed ID: 14594687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evaluation of survival, continence and potency (SCP) outcomes after robot-assisted radical prostatectomy (RARP).
    Ficarra V; Borghesi M; Suardi N; De Naeyer G; Novara G; Schatteman P; De Groote R; Carpentier P; Mottrie A
    BJU Int; 2013 Aug; 112(3):338-45. PubMed ID: 23470027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy.
    Berg KD; Thomsen FB; Hvarness H; Christensen IJ; Iversen P
    Scand J Urol; 2014 Aug; 48(4):356-66. PubMed ID: 24579803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience.
    Busch J; Stephan C; Herold A; Erber B; Kempkensteffen C; Hinz S; Lein M; Weikert S; Miller K; Magheli A
    BJU Int; 2012 Dec; 110(11 Pt C):E985-90. PubMed ID: 22672442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional outcomes of robot-assisted radical prostatectomy in patients eligible for active surveillance.
    Zanaty M; Ajib K; Zorn K; El-Hakim A
    World J Urol; 2018 Sep; 36(9):1391-1397. PubMed ID: 29680952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial.
    Hagman A; Lantz A; Carlsson S; Höijer J; Stranne J; Tyritzis SI; Haglind E; Bjartell A; Hugosson J; Akre O; Steineck G; Wiklund P
    World J Urol; 2021 Sep; 39(9):3239-3249. PubMed ID: 33743059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry.
    Ong WL; Evans SM; Spelman T; Kearns PA; Murphy DG; Millar JL
    BJU Int; 2016 Oct; 118(4):563-9. PubMed ID: 26573954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon.
    Patel VR; Coelho RF; Chauhan S; Orvieto MA; Palmer KJ; Rocco B; Sivaraman A; Coughlin G
    BJU Int; 2010 Sep; 106(5):696-702. PubMed ID: 20707793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer control.
    Xylinas E; Durand X; Ploussard G; Campeggi A; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    Urol Oncol; 2013 Jan; 31(1):99-103. PubMed ID: 21719321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological and functional outcomes following open radical prostatectomy: how patients may achieve the "Trifecta"?
    Antebi E; Eldefrawy A; Katkoori D; Soloway CT; Manoharan M; Soloway MS
    Int Braz J Urol; 2011; 37(3):320-7; discussion 327. PubMed ID: 21756379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
    Mitsuzuka K; Narita S; Koie T; Kaiho Y; Tsuchiya N; Yoneyama T; Kakoi N; Kawamura S; Tochigi T; Habuchi T; Ohyama C; Arai Y
    BJU Int; 2013 May; 111(6):914-20. PubMed ID: 23320782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary incontinence after radical prostatectomy: can men at risk be identified preoperatively?
    Moore KN; Truong V; Estey E; Voaklander DC
    J Wound Ostomy Continence Nurs; 2007; 34(3):270-9; quiz 280-1. PubMed ID: 17505246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-port transvesical laparoscopic radical prostatectomy for organ-confined prostate cancer: technique and outcomes.
    Gao X; Pang J; Si-tu J; Luo Y; Zhang H; Li LY; Zhang Y
    BJU Int; 2013 Nov; 112(7):944-52. PubMed ID: 23826929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
    Mandel P; Steuber T; Ahyai S; Kriegmair M; Schiffmann J; Boehm K; Heinzer H; Michl U; Schlomm T; Haese A; Huland H; Graefen M; Tilki D
    BJU Int; 2016 Jan; 117(1):55-61. PubMed ID: 25711672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimally invasive radical prostatectomy: Contribution of robotic support, functional and oncological outcomes].
    Hoepffner JL; Gaston R; Mugnier C; Rey D; Lopez L; Roche JB; Riviere J; Piechaud PT
    Bull Cancer; 2016 May; 103(5):461-8. PubMed ID: 26995400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer.
    Lawrentschuk N; Finelli A; Van der Kwast TH; Ryan P; Bolton DM; Fleshner NE; Trachtenberg J; Klotz L; Robinette M; Woo H
    J Urol; 2011 Mar; 185(3):862-8. PubMed ID: 21239003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis.
    Hatzichristodoulou G; Wagenpfeil S; Wagenpfeil G; Maurer T; Horn T; Herkommer K; Hegemann M; Gschwend JE; Kübler H
    World J Urol; 2016 Jun; 34(6):811-20. PubMed ID: 26420596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.